Onconova Therapeutics, Inc. (ONTX) Stock Skyrockets Following Reverse Stock Split
Onconova Therapeutics, Inc. (ONTX) stock prices were down by a substantial 21.08% as of the market closing on May 20th, 2021, bringing the price per share down to USD$0.73 at the end of the trading day. Subsequent pre-market fluctuations saw the price skyrocket by a monumental 1235.62%, bringing the price per share up to USD$9.69. […]
Onconova Therapeutics Inc. (ONTX) stock soars during current market. What is driving it high?
Onconova Therapeutics Inc. (NASDAQ: ONTX) stock gains by 29.45% during current market trading. Onconova Therapeutics is a clinical-stage biopharmaceutical corporation dedicated to the discovery and development of new cancer treatments. ONTX has developed patented selective anti-cancer agents that inhibit key cellular pathways involved in cancer cell proliferation. Financial Highlights On May 17, 2021, Onconova Therapeutics […]
Onconova Therapeutics Inc. (NASDAQ: ONTX) stock rises during pre-market. What is going on?
Onconova Therapeutics Inc. (NASDAQ: ONTX) stock plunged by 8.37% at last close whereas the ONTX stock price gains by 6.42% in the pre-market trading session. Onconova Therapeutics is a clinical-stage biopharmaceutical corporation dedicated to the discovery and development of new cancer treatments. ONTX has developed patented selective anti-cancer agents that inhibit key cellular pathways involved […]
Let’s take a look at why Onconova Therapeutics, Inc. (ONTX) surged in the Postmarket hours
Onconova Therapeutics, Inc. (NASDAQ: ONTX), shares rose above 37% to 0.586 in the post-market session today after the news that it has earned the U.S. Food and Drug Administration (FDA) clearance for a Phase 1 analysis to continue with ON 123300, a proprietary, differentiated, first-in-class multi-kinase inhibitor, under the Company’s Investigational New Drug Application (IND). […]